Pacific Biosciences of California (PACB)
Create an Alert
2.79
-0.01 -0.36%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Pacific Biosciences of California Revenue Quarterly YoY Growth:
-44.43% for Dec. 31, 2012Pacific Biosciences of California Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -44.43% |
| Dec. 31, 2012 | -52.76% |
| Sept. 30, 2012 | -73.61% |
| June 30, 2012 | -31.41% |
| March 31, 2012 | 3618% |
| Dec. 31, 2011 | 4344% |
| Sept. 30, 2011 | 4681% |
| June 30, 2011 | 1590% |
| March 31, 2011 | -50.46% |
| Dec. 31, 2010 | 107.4% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
PACB Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Infinity Pharmaceuticals | -100.0% |
| Aegerion Pharmaceuticals | |
| ARCA biopharma |
PACB Revenue Quarterly YoY Growth Rankings
| Overall |
54th percentile 7620 of 16782 |
| Sector |
50th percentile 699 of 1410 in Healthcare |
| Industry |
60th percentile 180 of 454 in Biotechnology |
PACB Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -73.61% | Sep 2012 |
| Maximum | 4681% | Sep 2011 |
| Average | 1409% |
